bmp-7
-
Recon
Ember Therapeutics Announce Initial Positive Results From a Phase 2 Trial of BMP-7 in Patients with Moderate Osteoarthritis of the Knee
NEW YORK, Oct. 19, 2015 /PRNewswire/ — Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis,…
Read More » -
Uncategorized
Mariel Therapeutics Announces Definitive Agreement to Acquire Stryker’s BMP-7 Assets
NEW YORK, July 7, 2014 /PRNewswire/ — Mariel Therapeutics, Inc. today announced that it has entered into a definitive agreement…
Read More »